“…8,9 To date, over ten synthetic studies of natural products and medicinal agents have been reported using the original Co(modp) 2 catalyst, improved catalyst systems [e.g., Co(nmp) 2 ], or reductive trapping pathways. Examples include syntheses of gigantetrocin A, 10 asimilobin, 11 mucocin, 12 bullatacin, 13 aplysiallene, 14 asimicin, 15 amphidinolides C and F, 9,16,17 goniotrionin, 18 compound CMI-977 (LDP-977), 19 bovidic acid, 20 cyclocapitelline, 21 and squamotacin C 22 (Figure 1). These impressive accomplishments illustrate the importance and versatility of this highly stereoselective oxidative cyclization.…”